Torrisi SE - Search Results

1

Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme.

Valenzuela C, Torrisi SE, Kahn N, Quaresma M, Stowasser S, Kreuter M. Valenzuela C, et al. Among authors: torrisi se. Respir Res. 2020 Jan 6;21(1):7. doi: 10.1186/s12931-019-1269-6. Respir Res. 2020. PMID: 31906942 Free PMC article. Review.

2

What We Know About the Pathogenesis of Idiopathic Pulmonary Fibrosis.

Puglisi S, Torrisi SE, Giuliano R, Vindigni V, Vancheri C. Puglisi S, et al. Among authors: torrisi se. Semin Respir Crit Care Med. 2016 Jun;37(3):358-67. doi: 10.1055/s-0036-1580693. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231860 Review.

3

When to start and when to stop antifibrotic therapies.

Torrisi SE, Pavone M, Vancheri A, Vancheri C. Torrisi SE, et al. Eur Respir Rev. 2017 Oct 3;26(145):170053. doi: 10.1183/16000617.0053-2017. Print 2017 Sep 30. Eur Respir Rev. 2017. PMID: 28974541 Free PMC article. Review.

4

The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study.

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C. Torrisi SE, et al. Eur Respir J. 2019 Mar 7;53(3):1801587. doi: 10.1183/13993003.01587-2018. Print 2019 Mar. Eur Respir J. 2019. PMID: 30578385 Free article.

5

Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients.

Sambataro G, Sambataro D, Torrisi SE, Vancheri A, Colaci M, Pavone M, Pignataro F, Del Papa N, Palmucci S, Vancheri C. Sambataro G, et al. Among authors: torrisi se. Respir Med. 2019 Apr;150:154-160. doi: 10.1016/j.rmed.2019.03.011. Epub 2019 Mar 25. Respir Med. 2019. PMID: 30961944 Free article.

6

Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C. Torrisi SE, et al. Eur Respir J. 2019 May 9;53(5):1900615. doi: 10.1183/13993003.00615-2019. Print 2019 May. Eur Respir J. 2019. PMID: 31072878 Free article. No abstract available.

7

The therapy of idiopathic pulmonary fibrosis: what is next?

Somogyi V, Chaudhuri N, Torrisi SE, Kahn N, Müller V, Kreuter M. Somogyi V, et al. Among authors: torrisi se. Eur Respir Rev. 2019 Sep 4;28(153):190021. doi: 10.1183/16000617.0021-2019. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31484664 Free PMC article. Review.

8

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.

Torrisi SE, Kahn N, Wälscher J, Sarmand N, Polke M, Lars K, Eichinger M, Heussel CP, Palmucci S, Sambataro FM, Sambataro G, Sambataro D, Vancheri C, Kreuter M. Torrisi SE, et al. BMC Pulm Med. 2019 Nov 12;19(1):213. doi: 10.1186/s12890-019-0937-0. BMC Pulm Med. 2019. PMID: 31718637 Free PMC article.

9

Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis.

Palmucci S, Torrisi SE, Falsaperla D, Stefano A, Torcitto AG, Russo G, Pavone M, Vancheri A, Mauro LA, Grassedonio E, Sambataro G, Puglisi S, Piciucchi S, Tomassetti S, Poletti V, Basile A, Vancheri C. Palmucci S, et al. Among authors: torrisi se. J Thorac Imaging. 2020 Mar;35(2):115-122. doi: 10.1097/RTI.0000000000000468. J Thorac Imaging. 2020. PMID: 31913257

10

Evolution and treatment of idiopathic pulmonary fibrosis.

Torrisi SE, Kahn N, Vancheri C, Kreuter M. Torrisi SE, et al. Presse Med. 2020 Jun;49(2):104025. doi: 10.1016/j.lpm.2020.104025. Epub 2020 May 11. Presse Med. 2020. PMID: 32437841 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page